273 255 322 281 250 329 342 230 261 154 185 210 332 302 273 . 2016 NTP Report 5a. Treatment Outcome of DS-TB Cases "020617 Cured 77 29 60 171 305 47 100 62 16 81 218 116 33 60 27 1,405

Page 1 <img data-url='document/273-255-322-281-250-329-342-230-261-154-185-210-332-302-273-2016-ntp-report-5a.html?page=1' data-page='1' class='cut-thumb lazyload' alt='Page 1: 273 255 322 281 250 329 342 230 261 154 185 210 332 302 273 . 2016 NTP Report 5a. Treatment Outcome of DS-TB Cases "020617 Cured 77 29 60 171 305 47 100 62 16 81 218 116 33 60 27 1,405' loading='lazy' src='data:image/gif;base64,iVBORw0KGgoAAAANSUhEUgAAAAEAAAABCAYAAAAfFcSJAAAADUlEQVR42mNk+P+/HgAFhAJ/wlseKgAAAABJRU5ErkJggg==' data-src='https://reader030.cupdf.com/reader030/viewer/2022040914/5e8a4a50b226db6a7e61fa21/html5/thumbnails/1.jpg' width='140' height='200' /> Page 2 <img data-url='document/273-255-322-281-250-329-342-230-261-154-185-210-332-302-273-2016-ntp-report-5a.html?page=2' data-page='2' class='cut-thumb lazyload' alt='Page 2: 273 255 322 281 250 329 342 230 261 154 185 210 332 302 273 . 2016 NTP Report 5a. Treatment Outcome of DS-TB Cases "020617 Cured 77 29 60 171 305 47 100 62 16 81 218 116 33 60 27 1,405' loading='lazy' src='data:image/gif;base64,iVBORw0KGgoAAAANSUhEUgAAAAEAAAABCAYAAAAfFcSJAAAADUlEQVR42mNk+P+/HgAFhAJ/wlseKgAAAABJRU5ErkJggg==' data-src='https://reader030.cupdf.com/reader030/viewer/2022040914/5e8a4a50b226db6a7e61fa21/html5/thumbnails/2.jpg' width='140' height='200' /> Page 3 <img data-url='document/273-255-322-281-250-329-342-230-261-154-185-210-332-302-273-2016-ntp-report-5a.html?page=3' data-page='3' class='cut-thumb lazyload' alt='Page 3: 273 255 322 281 250 329 342 230 261 154 185 210 332 302 273 . 2016 NTP Report 5a. Treatment Outcome of DS-TB Cases "020617 Cured 77 29 60 171 305 47 100 62 16 81 218 116 33 60 27 1,405' loading='lazy' src='data:image/gif;base64,iVBORw0KGgoAAAANSUhEUgAAAAEAAAABCAYAAAAfFcSJAAAADUlEQVR42mNk+P+/HgAFhAJ/wlseKgAAAABJRU5ErkJggg==' data-src='https://reader030.cupdf.com/reader030/viewer/2022040914/5e8a4a50b226db6a7e61fa21/html5/thumbnails/3.jpg' width='140' height='200' /> Page 4 <img data-url='document/273-255-322-281-250-329-342-230-261-154-185-210-332-302-273-2016-ntp-report-5a.html?page=4' data-page='4' class='cut-thumb lazyload' alt='Page 4: 273 255 322 281 250 329 342 230 261 154 185 210 332 302 273 . 2016 NTP Report 5a. Treatment Outcome of DS-TB Cases "020617 Cured 77 29 60 171 305 47 100 62 16 81 218 116 33 60 27 1,405' loading='lazy' src='data:image/gif;base64,iVBORw0KGgoAAAANSUhEUgAAAAEAAAABCAYAAAAfFcSJAAAADUlEQVR42mNk+P+/HgAFhAJ/wlseKgAAAABJRU5ErkJggg==' data-src='https://reader030.cupdf.com/reader030/viewer/2022040914/5e8a4a50b226db6a7e61fa21/html5/thumbnails/4.jpg' width='140' height='200' /> Page 5 <img data-url='document/273-255-322-281-250-329-342-230-261-154-185-210-332-302-273-2016-ntp-report-5a.html?page=5' data-page='5' class='cut-thumb lazyload' alt='Page 5: 273 255 322 281 250 329 342 230 261 154 185 210 332 302 273 . 2016 NTP Report 5a. Treatment Outcome of DS-TB Cases "020617 Cured 77 29 60 171 305 47 100 62 16 81 218 116 33 60 27 1,405' loading='lazy' src='data:image/gif;base64,iVBORw0KGgoAAAANSUhEUgAAAAEAAAABCAYAAAAfFcSJAAAADUlEQVR42mNk+P+/HgAFhAJ/wlseKgAAAABJRU5ErkJggg==' data-src='https://reader030.cupdf.com/reader030/viewer/2022040914/5e8a4a50b226db6a7e61fa21/html5/thumbnails/5.jpg' width='140' height='200' /> Page 6 <img data-url='document/273-255-322-281-250-329-342-230-261-154-185-210-332-302-273-2016-ntp-report-5a.html?page=6' data-page='6' class='cut-thumb lazyload' alt='Page 6: 273 255 322 281 250 329 342 230 261 154 185 210 332 302 273 . 2016 NTP Report 5a. Treatment Outcome of DS-TB Cases "020617 Cured 77 29 60 171 305 47 100 62 16 81 218 116 33 60 27 1,405' loading='lazy' src='data:image/gif;base64,iVBORw0KGgoAAAANSUhEUgAAAAEAAAABCAYAAAAfFcSJAAAADUlEQVR42mNk+P+/HgAFhAJ/wlseKgAAAABJRU5ErkJggg==' data-src='https://reader030.cupdf.com/reader030/viewer/2022040914/5e8a4a50b226db6a7e61fa21/html5/thumbnails/6.jpg' width='140' height='200' /> Page 7 <img data-url='document/273-255-322-281-250-329-342-230-261-154-185-210-332-302-273-2016-ntp-report-5a.html?page=7' data-page='7' class='cut-thumb lazyload' alt='Page 7: 273 255 322 281 250 329 342 230 261 154 185 210 332 302 273 . 2016 NTP Report 5a. Treatment Outcome of DS-TB Cases "020617 Cured 77 29 60 171 305 47 100 62 16 81 218 116 33 60 27 1,405' loading='lazy' src='data:image/gif;base64,iVBORw0KGgoAAAANSUhEUgAAAAEAAAABCAYAAAAfFcSJAAAADUlEQVR42mNk+P+/HgAFhAJ/wlseKgAAAABJRU5ErkJggg==' data-src='https://reader030.cupdf.com/reader030/viewer/2022040914/5e8a4a50b226db6a7e61fa21/html5/thumbnails/7.jpg' width='140' height='200' /> Page 8 <img data-url='document/273-255-322-281-250-329-342-230-261-154-185-210-332-302-273-2016-ntp-report-5a.html?page=8' data-page='8' class='cut-thumb lazyload' alt='Page 8: 273 255 322 281 250 329 342 230 261 154 185 210 332 302 273 . 2016 NTP Report 5a. Treatment Outcome of DS-TB Cases "020617 Cured 77 29 60 171 305 47 100 62 16 81 218 116 33 60 27 1,405' loading='lazy' src='data:image/gif;base64,iVBORw0KGgoAAAANSUhEUgAAAAEAAAABCAYAAAAfFcSJAAAADUlEQVR42mNk+P+/HgAFhAJ/wlseKgAAAABJRU5ErkJggg==' data-src='https://reader030.cupdf.com/reader030/viewer/2022040914/5e8a4a50b226db6a7e61fa21/html5/thumbnails/8.jpg' width='140' height='200' />

273 255 322 281 250 329 342 230 261 154 185 210 332 302 273 . 2016 NTP Report 5a. Treatment Outcome of DS-TB Cases "020617 Cured 77 29 60 171 305 47 100 62 16 81 218 116 33 60 27 1,405

Documents